Suchergebnisse - "Viktrup, Lars"

PubPharm (209)

1

Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months : a US retrospective claims study

enthalten in: Current medical research and opinion | 2024

von Varnado, O. | Vu, M. | Buysman, E. | +6

2

Effect size varies based on calculation method and may affect interpretation of treatment effect : an illustration using randomised clinical trials in osteoarthritis

enthalten in: Advances in rheumatology (London, England) | 2024

von Schnitzer, T. | Conaghan, P. | Berenbaum, F. | +6

3

Effect size varies based on calculation method and may affect interpretation of treatment effect: an illustration using randomised clinical trials in osteoarthritis

enthalten in: Advances in rheumatology | 2024

von Schnitzer, T. | Conaghan, P. | Berenbaum, F. | +6

4

Characterization of adverse joint outcomes in patients with osteoarthritis treated with subcutaneous tanezumab

enthalten in: Osteoarthritis and cartilage | 2023

von Carrino, J. | McAlindon, T. | Schnitzer, T. | +10

5

A Randomized Placebo-Controlled Trial of the Anti-Nerve Growth Factor Antibody Tanezumab in Subjects With Cancer Pain Due to Bone Metastasis

enthalten in: The oncologist | 2023

von Fallon, M. | Sopata, M. | Dragon, E. | +5

6

Reliability of Wearable Sensors for Assessing Gait and Chair Stand Function at Home in People With Knee Osteoarthritis

enthalten in: Arthritis care & research | 2023

von Rose, M. | Neogi, T. | Friscia, B. | +9

7

Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab : Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis

enthalten in: Clinical drug investigation | 2023

von Brown, M. | Cornblath, D. | Koltzenburg, M. | +6

8

Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis

enthalten in: Clinical drug investigation | 2023

von Brown, M. | Cornblath, D. | Koltzenburg, M. | +6

9

Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis

enthalten in: Clinical drug investigation | 2023

von Brown, M. | Cornblath, D. | Koltzenburg, M. | +6

10

Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis

enthalten in: Clinical drug investigation | 2023

von Brown, M. | Cornblath, D. | Koltzenburg, M. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]